Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$7.22 - $10.05 $127,072 - $176,880
17,600 New
17,600 $136,000
Q3 2022

Nov 14, 2022

BUY
$3.09 - $9.21 $39,005 - $116,257
12,623 New
12,623 $40,000
Q2 2022

Aug 15, 2022

SELL
$5.7 - $10.33 $99,750 - $180,775
-17,500 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$21.07 - $34.98 $368,725 - $612,150
17,500 New
17,500 $400,000

Others Institutions Holding ICVX

About Icosavax, Inc.


  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.